Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growth

Human Gene Therapy

Volumn 10, Issue 12, 1999, Pages 1941-1951

  Evans, Lawrence S ^a,b   Witte, Pamela R ^a,c   Feldbaus, Andrew L ^a,d   Nelson, Brad H ^e   Riddell, Stanley R ^f   Greenberg, Philip D ^f,g   Lupton, Stephen D ^a,h   Jones, Lori A ^a,i  

^a Targeted Genetics Corporation   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d ZYMOGENETICS INC   (United States)

^e BENAROYA RESEARCH INSTITUTE   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h ALZA CORPORATION   (United States)

ⁱ Northwest Biotherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL GROWTH; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; RECEPTOR BINDING; VIRUS INFECTION;

ANIMALS; FLOW CYTOMETRY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 4; MURINAE;

EID: 0033543128     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017301     Document Type: Article

References (26)

1. ADAM, M.A., RAMESH, N., MILLER, A.D., and OSBORNE, W.R. (1991). Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J. Virol. 65, 4985-4990.
2. ALEXANDER, R.B., and ROSENBERG, S.A. (1991). Adoptively transferred tumor-infiltrating lymphocytes can cure established metastatic tumor in mice and persist long-term in vivo as functional memory T lymphocytes. J. Immunother. 10, 389-397.
3. BIERER, B.E., BARBOSA, J., HERMANN, S., and BURAKOFF, S.J. (1988). Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation. J. Immunol. 140, 3358-3363.
4. BOCCHIA, M., KORONTSVIT, T., XU, Q., MACKINNON, S., YANG, S.Y., SETTE, A., and SCHEINBERG, D.A. (1996). Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87, 3587-3592.
5. BONINI, C., FERRARI, G., VERZELETTI, S., SERVIDA, P., ZAPPONE, E., RUGGIERI, L., PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
6. BOWLES, N.B., EISENSMITH, R.C., MOHUIDDIN, R., PYRON, M., and WOO, S.L. (1996). A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum. Gene Ther. 7, 1735-1742.
7. CHEEVER, M.A., and CHEN, W. (1997). Therapy with cultured T cells: Principles revisited. Immunol. Rev. 157, 177-194.
8. DALGLEISH, A.G. (1994). The role of IL-2 in gene therapy. Gene Ther. 1, 83-87.
9. FELDHAUS, A.L., EVANS, L., SUTHERLAND, R.A., and JONES, L.A. (1997). A CD2/CD28 chimeric receptor triggers the CD28 signaling pathway in CTLL.2 cell. Gene Ther. 4, 833-838.
10. GREENBERG, P.D., and NELSON, B.H. (1998). Chimeric cytokine receptors in lymphocytes. U.S. patent number 5,747,292.
11. HESLOP, H.E., and ROONEY, C.M. (1997). Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol. Rev. 157, 217-222.
12. HESLOP, H.E., NG, C.Y., LI, C., SMITH, C.A., LOFTIN, S.K., KRANCE, R.A., BRENNER, M.K., and ROONEY, C.M. (1996). Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med. 2, 551-555.
13. KLARNET, J.P., MATIS, L.A., KERN, D.E., MIZUNO, M.T., PEACE, D.J., THOMPSON, J.A., GREENBERG, P.D., and CHEEVER, M.A. (1987). Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory. J. Immunol. 138, 4012-4017.
14. LUPTON, S.D., BRUNTON, L.L., KALBERG, V.A., and OVERELL, R.W. (1991). Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11, 3374-3378.
15. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8656-8063.
16. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
17. MILLER, A.D., GARCIA, J.V., VON SUHR, N., LYNCH, C.M., WILSON, C., and EIDEN, M.V. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
18. MINAMOTO, S., TREISMAN, J., HANKINS, W.D., SUGAMURA, K., and ROSENBERG, S.A. (1995). Acquired erythropoietin responsiveness of interleukin-2-dependent T lymphocytes retrovirally transduced with genes encoding chimeric erythropoietin/interleukin-2 receptors. Blood 86, 2281-2287.
19. NELSON, B.H., LORD, J.D., and GREENBERG, P.D. (1994). Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature (London) 369, 333-336.
20. RIDDELL, S.R., and GREENBERG, P.D. (1995). Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13, 545-586.
21. RIDDELL, S.R., ELLIOT, M., LEWINSOHN, D.A., GILBERT, M.J., WILSON, L., MANLEY, S.A., LUPTON, S.D., OVERALL, R.W., REYNOLDS, T.C., COREY, L., and GREENBERG, P.D. (1996). T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med. 2, 216-223.
22. SALGAME, P., ABRAMS, J.S., CLAYBERGER, C., GOLDSTEIN, H., CONVIT, J., MODLIN, R.L., and BLOOM, B.R. (1991). Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254, 279-282.
23. + cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. J. Immunol. 144, 4156-4162.
24. TEN BOSCH, G.J., TOORNVLIET, A.C., FRIEDE, T., MELIEF, C.J., and LEEKSMA, O.C. (1995). Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. Leukemia 9, 1344-1348.
25. VALERA, A., PERALES, J.C., HATZOGLOU, M., and BOSCH, F. (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5, 449-456.
26. WALTER, E.A., GREENBERG, P.D., GILBERT, M.J., FINCH, R.J., WATANABE, K.S., THOMAS, E.D., and RIDDELL, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.